- Enzyme Activators
- Accession Number
Compounds or factors that act on a specific enzyme to increase its activity.
Drug Drug Description SRT-2104 SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2. Riociguat A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Ataciguat Ataciguat has been investigated for the basic science of Aortic Valve Stenosis. LY-2608204 LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2. Linaclotide A guanylate cyclase-C agonist used to treat different types of constipation, such as irritable bowel syndrome-related constipation, idiopathic constipation, and functional constipation. Pirnabine Pirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation. Dolcanatide Dolcanatide has been investigated in Exposure. Plecanatide A laxative used to treat chronic idiopathic constipation and IBS with constipation. Praliciguat Praliciguat is under investigation in clinical trial NCT03254485 (A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (Hfpef)). Mitapivat A pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
- Drugs & Drug Targets